Skip to content
10-Q

Quarterly Report

THC Farmaceuticals, Inc.

0001515971-15-000306

← back to feed
Filed
Aug 19, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Aug 12, 2015 15M sh
Operating Cash Flow Q3 2015 · Jun 30, 2015 −$1.51M
Operating Cash Flow Q3 2015 · Jun 30, 2014 −$16.41K
Stockholders Equity Q3 2015 · Jun 30, 2015 $1.01M
Stockholders Equity Q3 2015 · Sep 30, 2014 −$48.02K
Current Liabilities Q3 2015 · Jun 30, 2015 $16.18K
Current Liabilities Q3 2015 · Sep 30, 2014 $5.98K
Total Liabilities Q3 2015 · Jun 30, 2015 $700.98K
Total Liabilities Q3 2015 · Sep 30, 2014 $96.17K
Current Assets Q3 2015 · Jun 30, 2015 $31.99K
Current Assets Q3 2015 · Sep 30, 2014 $2.39K
Total Assets Q3 2015 · Jun 30, 2015 $1.72M
Total Assets Q3 2015 · Sep 30, 2014 $48.15K
Sga Expense Q3 2015 · Jun 30, 2015 $35.24K
Sga Expense Q3 2015 · Jun 30, 2015 $65.15K
Sga Expense Q3 2015 · Jun 30, 2014 $4.01K
Sga Expense Q3 2015 · Jun 30, 2014 $21.46K
Net Income Q3 2015 · Jun 30, 2015 −$35.69K
Net Income Q3 2015 · Jun 30, 2015 −$63.85K
Net Income Q3 2015 · Jun 30, 2014 −$4.25K
Net Income Q3 2015 · Jun 30, 2014 −$22.08K
Operating Income Q3 2015 · Jun 30, 2015 −$35.39K
Operating Income Q3 2015 · Jun 30, 2015 −$63.28K
Operating Income Q3 2015 · Jun 30, 2014 −$2.49K
Operating Income Q3 2015 · Jun 30, 2014 −$17.26K
Revenue Q3 2015 · Jun 30, 2015 $4.5K
Revenue Q3 2015 · Jun 30, 2015 $13.73K
Revenue Q3 2015 · Jun 30, 2014 $4.37K
Revenue restated Q3 2015 · Jun 30, 2014 $14.25K